Erratum: Fluorescence assay of SIRT protein deacetylases using an acetylated peptide substrate and a secondary trypsin reaction (Analytical Biochemistry (2004) 332 (90-99) DOI: 10.1016/j.ab.2004.05.039);Fluorescence assay of SIRT protein deacetylases using an acetylated peptide substrate and a secondary trypsin reaction

Analytical Biochemistry

Volumn 332, Issue 1, 2004, Pages 90-99

  Marcotte, Patrick A ^a   Richardson, Paul R ^a   Guo, Jun ^a   Barrett, Leo W ^a   Xu, Nan ^a   Gunasekera, Angelo ^a   Glaser, Keith B ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Fluorescence assays; FRET assays; HDAC; Histone deacetylase; Sirtuin deacetylase

Indexed keywords

ACETYLATION; AMINO ACIDS; BIOCHEMISTRY; PEPTIDES; REACTION KINETICS;

DEACETYLASE; FLUORESCENCE ASSAY; HDAC; HISTONE DEACETYLASES; MILLIMOLAR CONCENTRATIONS; NICOTINAMIDE ADENINE DINUCLEOTIDES; PEPTIDE SEQUENCES; PEPTIDE SUBSTRATES;

FLUORESCENCE;

ARGININE; CARBOXYLIC ACID DERIVATIVE; LYSINE; NICOTINAMIDE; PEPTIDE DERIVATIVE; PROTEIN P53; SERINE; SIRTUIN; TETRAMETHYLRHODAMINE 6 CARBOXYLIC ACID; TRYPSIN; UNCLASSIFIED DRUG;

ACETYLATION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMICAL REACTION; CONCENTRATION (PARAMETERS); FLUORESCENCE; MICROTITER PLATE ASSAY; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 4143100391     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2005.12.022     Document Type: Erratum

References (29)

1. Denu J.M. Linking chromatin function with metabolic networks: sir2 family of NAD(+)-dependent deacetylases. Trends Biochem. Sci. 28:2003;41-48
2. Smith J.S., Avalos J., Celic I., Muhammad S., Wolberger C., Boeke J.D. SIR2 family of NAD(+)-dependent protein deacetylases. Methods Enzymol. 353:2002;282-300
3. Gotta M., Strahl-Bolsinger S., Renauld H., Laroche T., Kennedy B.K., Grunstein M., Gasser S.M. Localization of Sir2p: the nucleolus as a compartment for silent information regulators. EMBO J. 16:1997;3243-3255
4. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273:2000;793-798
5. Imai S-I., Armstrong C.M., Kaeberlein M., Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 403:2000;795-800
6. Gray S.G., Ekstrom T.J. The human histone deacetylase family. Exp. Cell Res. 262:2001;75-83
7. Tanner K.G., Landry J., Sternglanz R., Denu J.M. Silent information regulator-2 family of NAD-dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc. Natl. Acad. Sci. USA. 97:2000;14178-14182
8. Avalos J.L., Celic I., Muhammad S., Cosgrove M.S., Boeke J.D., Wolberger C. Structure of a Sir2 enzyme bound to an acetylated p53 peptide. Mol. Cell. 10:2002;523-535
9. Vaziri H., Dessain S.K., Eagon E.N., Imai S.-I., Frye R.A., Pandita T.K., Guarente L., Weinberg R.A. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 107:2001;149-159
10. Cheng H.L., Mostoslavsky R., Saito S., Manis J.P., Gu Y., Patel P., Bronson R., Appella E., Alt F.W., Chua K.F. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl. Acad. Sci. USA. 100:2003;10794-10799
11. Gu W., Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 90:1997;595-606
12. Luo J., Nikolaev A.Y., Imai S.-I., Chen D.L., Su F., Shiloh A., Guarente L., Gu W. Negative control of p53 by Sir2-alpha promotes cell survival under stress. Cell. 107:2001;137-148
13. Smith J.S. Human Sir2 and the "silencing" of p53 activity. Trends Cell Biol. 12:2002;404-406
14. Langley E., Pearson M., Faretta M., Bauer U.M., Frye R.A., Minucci S., Pelicci P.G., Kouzarides T. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21:2002;2383-2396
15. Grozinger C.M., Chao E.D., Blackwell H.E., Moazed D., Schreiber S.L. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J. Biol. Chem. 276:2001;38837-38843
16. Onyango P., Celic I., McCaffery J.M., Boeke J.D., Feinberg A.P. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc. Natl. Acad. Sci. USA. 99:2002;13653-13658
17. Bedalov A., Gatbonton T., Irvine W.P., Gottschling D.E., Simon J.A. Identification of a small molecule inhibitor of Sir2p. Proc. Natl. Acad. Sci. USA. 98:2001;15113-15118
18. ′ -O-acetyl-ADP-ribose as novel metabolites derived from the Sir2 family of beta-NAD(+)-dependent histone/protein deacetylases J. Biol. Chem. 277:2002;18535-18544
19. Bitterman K.J., Anderson R.M., Cohen H.Y., Latorre-Esteves M., Sinclair D.A. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast Sir2 and human SIRT1. J. Biol. Chem. 277:2002;45099-45107
20. Saito A., Yamashita T., Mariko Y., Nosaka Y., Tsuchiya K., Ando T., Suzuki T., Tsuruo T., Nakanishi O. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc. Natl. Acad. Sci. USA. 96:1999;4592-4597
21. Marcotte P.A., Davidsen S.K. Characterization of matrix metalloproteinase inhibitors: Enzymatic assays. Enna S.J., Williams M., Ferkany J.W., Kenakin T., Porsolt R.D., Sullivan J.P. Current Protocols in Pharmacology. 2001;3.7.1-3.7.14 John Wiley, New York
22. Zakut-Houri R., Bienz-Tadmor B., Givol D., Oren M. Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. EMBO J. 4:1985;1251-1255
23. Dai Y., Guo Y., Guo J., Pease L.J., Li J., Marcotte P.A., Glaser K.B., Tapang P., Albert D.H., Richardson P.L., Davidsen S.K., Michaelides M.R. Indole amide hydroxamic acids as potent inhibitors of histone deacetylases. Bioorg. Med. Chem. Lett. 13:2003;1897-1901
24. Wada C.K., Frey R.R., Ji Z., Curtin M.L., Garland R.B., Holms J.H., Li J., Pease L.J., Guo J., Glaser K.B., Marcotte P.A., Richardson P.L., Murphy S.S., Bouska J.J., Tapang P., Magoc T.J., Albert D.H., Davidsen S.K., Michaelides M.R. Alpha-keto amides as inhibitors of histone deacetylase. Bioorg. Med. Chem. Lett. 13:2003;3331-3335
25. Dai Y., Guo Y., Curtin M.L., Li J., Pease L.J., Guo J., Marcotte P.A., Glaser K.B., Davidsen S.K., Michaelides M.R. A novel series of histone deacetylase inhibitors incorporating hetero aromatic ring systems as connection units. Bioorg. Med. Chem. Lett. 13:2003;3817-3820
26. Vasudevan A., Ji Z., Frey R.R., Wada C.K., Steinman D., Heyman H.R., Guo Y., Curtin M.L., Guo J., Li J., Pease L., Glaser K.B., Marcotte P.A., Bouska J.J., Davidsen S.K., Michaelides M.R. Heterocyclic ketones as inhibitors of histone deacetylase. Bioorg. Med. Chem. Lett. 13:2003;3909-3913
27. Hayashi T., Ohe Y., Hayashi H., Iwai K. Human spleen histone H4: isolation and amino acid sequence. J. Biochem. (Tokyo). 92:1982;1995-2000
28. G.A. Hofmann, E. Hu, J.D. Winkler, X.L. Zhang, J.D. Martin, W-S. Liu, S.A. Carr, T. Meek, R. Macarron, A novel homogeneous fluorescent method to monitor histone deacetylase activity, in: Sixth Annual Conference of the Society for Biomolecular Screening, September 6-9, 2000, Vancouver, British Columbia, p. 209
29. Hu E., Dul E., Sung C.M., Chen Z., Kirkpatrick R., Zhang G.F., Johanson K., Liu R., Lago A., Hofmann G., Macarron R., de los Frailes M., Perez P., Krawiec J., Winkler J., Jaye M. Identification of novel isoform-selective inhibitors within class I histone deacetylases. J. Pharmacol. Exp. Ther. 307:2003;720-728